Janssen R&d Ireland
United States
No tags have been applied so far. Sign in to add some.
Janssen R&d Ireland
East Gate Village, East Gate
Little Island CO CORK
IRELAND
Profile
Timeline
Documents (0)
Litigation (26)
Over Time
Attorneys (38)
Stock Market (0)
Related (0)
Patent Assignments (299)
Trademark Assignments (450)
Locations (8)
Payments (0)
Federal Dockets
39
Active
2010–2020
Patent Assignments
299
Trademark Assignments
450
On PlainSite Chat
No one has posted about Janssen R&d Ireland yet.
Share something about Janssen R&d Ireland:
2/5/2020
California Northern District Court
3:20-cv-00880
KPH Healthcare Services, Inc. v. Gilead Holdings, LLC
Defendant
1/15/2020
Florida Southern District Court
1:20-cv-20170
MSP Recovery Claims, Series LLC v. GILEAD SCIENCES, INC.
Defendant
7/22/2019
Georgia Northern District Court
1:19-cv-03299
Abreu Velez v. Gilead Sciences, Inc.
Defendant
6/12/2019
California Northern District Court
3:19-cv-03311
Pipe Trades Services MN Welfare Fund v. Gilead Sciences, Inc...
Defendant
6/6/2019
California Northern District Court
3:19-cv-03142
Teamsters Local 237 Welfare Fund v. Gilead Sciences, Inc.
Defendant
5/20/2019
California Northern District Court
3:19-cv-02734
Snipe v. Gilead Sciences, Inc.
Defendant
8/15/2014
New Jersey District Court
2:14-cv-05093
JANSSEN PRODUCTS, L.P. v. CIPLA LTD.
Plaintiff
8/15/2014
New Jersey District Court
2:14-cv-05093
JANSSEN PRODUCTS, L.P. v. CIPLA LTD.
Counter Defendant
8/15/2014
Delaware District Court
1:14-cv-01056
Janssen Products LP et al v. Cipla Ltd. et al
Plaintiff
7/23/2014
New Jersey District Court
2:14-cv-04550
JANSSEN PRODUCTS, L.P. et al v. MYLAN PHARMACEUTICALS INC. e...
Plaintiff
7/23/2014
New Jersey District Court
2:14-cv-04550
JANSSEN PRODUCTS, L.P. et al v. MYLAN PHARMACEUTICALS INC. e...
Counter Defendant
3/24/2014
USPTO Trademark Trial and Appeal Board
91215567-OPP
Glaxosmithkline Intellectual Property Limited v. Janssen R&d...
Defendant
3/4/2014
New Jersey District Court
2:14-cv-01370
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Plaintiff
3/4/2014
New Jersey District Court
2:14-cv-01370
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Counter Defendant
11/27/2013
New Jersey District Court
2:13-cv-07576
JANSSEN PRODUCTS, L.P. et al v. TEVA PHARMACEUTICALS USA, IN...
Plaintiff
11/25/2013
USPTO Trademark Trial and Appeal Board
91213665-OPP
Janssen R&d Ireland v. Teva Pharmaceutical Industries Limite...
Plaintiff
10/16/2013
USPTO Trademark Trial and Appeal Board
85845780-EXT
Glaxosmithkline Intellectual Property Limited v. Janssen R&d...
Defendant
6/24/2013
New Jersey District Court
2:13-cv-03891
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Plaintiff
6/24/2013
New Jersey District Court
2:13-cv-03891
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Counter Defendant
6/21/2013
USPTO Trademark Trial and Appeal Board
85857195-EXT
Janssen R&d Ireland v. Teva Pharmaceuticals Europe B.v.
Potential Opposer
3/8/2013
New Jersey District Court
2:13-cv-01444
JANSSEN PRODUCTS, L.P. et al v. HETERO DRUGS, LTD. et al
Plaintiff
3/8/2013
New Jersey District Court
2:13-cv-01444
JANSSEN PRODUCTS, L.P. et al v. HETERO DRUGS, LTD. et al
Counter Defendant
12/11/2012
USPTO Trademark Trial and Appeal Board
91208377-OPP
Merck Kgaa v. Janssen R&d Ireland
Defendant
9/25/2012
USPTO Trademark Trial and Appeal Board
85283635-EXT
Merck Kgaa v. Janssen R&d Ireland
Defendant
8/24/2012
New Jersey District Court
2:12-cv-05358
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Plaintiff
7/30/2012
USPTO Trademark Trial and Appeal Board
85283635-EXA
In re Janssen R&d Ireland, Serial No. 85283635
Plaintiff
6/13/2012
New Jersey District Court
2:12-cv-03569
JANSSEN PRODUCTS, L.P. et al v. TEVA PHARMACEUTICALS USA, IN...
Plaintiff
6/13/2012
New Jersey District Court
2:12-cv-03569
JANSSEN PRODUCTS, L.P. et al v. TEVA PHARMACEUTICALS USA, IN...
Counter Defendant
6/13/2012
New Jersey District Court
2:12-cv-03570
JANSSEN PRODUCTS, L.P. et al v. HETERO DRUGS, LTD., UNIT III...
Plaintiff
5/10/2012
New Jersey District Court
2:12-cv-02840
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Plaintiff
5/10/2012
New Jersey District Court
2:12-cv-02840
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Counter Defendant
3/24/2011
New Jersey District Court
2:11-cv-01696
TIBOTEC INC., ET AL V. HETERO DRUGS, LTD.UNIT III, et al
Plaintiff
11/15/2010
New Jersey District Court
2:10-cv-05954
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Plaintiff
11/15/2010
New Jersey District Court
2:10-cv-05954
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Counter Defendant
11/15/2010
New Jersey District Court
2:10-cv-05954
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Counter Defendant
11/15/2010
New Jersey District Court
2:10-cv-05954
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Counter Defendant
11/15/2010
New Jersey District Court
2:10-cv-05954
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Counter Defendant
11/15/2010
New Jersey District Court
2:10-cv-05954
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Counter Defendant
11/15/2010
New Jersey District Court
2:10-cv-05954
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al
Counter Defendant
Outside Counsel (38)
JOHNSON & JOHNSON
New Brunswick, NJ
Johnson & Johnson, Inc.
NEW BRUNSWICK, NJ
Fross Zelnick Lehrman & Zissu, PC
Anania
Mark
Hamilton
Stevens & Lee, PC
Lawrenceville, NJ
Balick
Steven
J.
ashbygeddes.com Law Firm Placeholder
Wilmington, DE
BAUMEISTER
KIRK
Johnson & Johnson, Inc.
New Brunswick, NJ
Deberardine
Robert
JOHNSON & JOHNSON
New Brunswick, NJ
DISKANT
GREGORY
L.
Law Offices of Jane Marie Metcalf
New York, NY
Dragel
Jason
M.
Epstein Drangel Bazerman and James LLP
New York, NY
Engelman
Mark
D.
Fross Zelnick Lehrman & Zissu, PC
Finan
Therese
Patton Boggs LLP
McLean, VA
FLAHERTY
JOHN
EDMUND
McCarter & English LLP
NEWARK, NJ
Gelernter
Eugene
M
Law Offices of Jane Marie Metcalf
NY, NY
Harris
Robert
Stack Fernandez Anderson & Harris, PA
Miami, FL
Herbert
Toni-junell
Washington, DC
Jaenicke
Brian
T.
Johnson & Johnson, Inc.
New Brunswick, NJ
Johnson
Philip
ONE J&J PLAZA
New Brunswick, NJ
Johnson
Philip
S.
JOHNSON & JOHNSON
New Brunswick, NJ
Johnson.
Philip
S.
Johnson & Johnson, Inc.
New Brunswick, NJ
King
Annie
Fish & Richardson, PC
MINNEAPOLIS, MN
Koenigbauer
Fabian
Washington, DC
LIU
ZHIQIANG
Law Offices of Jane Marie Metcalf
New York, NY
Lydon
Tiffany
Geyer
Ashby & Geddes, PA
Wilmington, DE
Mayo
Andrew
Colin
ashbygeddes.com Law Firm Placeholder
Wilmington, DE
Mishra
Anjan
Law Offices of Jane Marie Metcalf
Patel
Ravin
R.
McCarter & English LLP
NEWARK, NJ
Pharmaceuticals
Tibotec
Placeholder
TTAB
Attorney
Drinker Biddle & Reath LLP
New York, NY
Plantz
Bernard
F.
JOHNSON & JOHNSON
New Brunswick, NJ
RODRIGUE
CARISSA
L.
McCarter & English LLP
NEWARK, NJ
Royzman
Irena
Law Offices of Jane Marie Metcalf
Shirtz
Joseph
ONE JOHNSON & JOHNSON PLAZA
New Brunswick, NJ
Short
Jonathan
M
McCarter & English LLP
Newark, NJ
SLAVIN
ELINA
Saul Ewing LLP
Newark, NJ
Solomon
Barbara
A.
Fross Zelnick Lehrman & Zissu, PC
New York, NY
St.
Norm
D.
Drinker Biddle & Reath LLP
Washington, DC
Strong
Christopher
Matthew
Law Offices of Jane Marie Metcalf
Yue
Herman
Heng
Patterson, Belknap, Webb & Tyler, LLP
10/29/2020
Gilead Sciences, Inc.
Assignor
Application Publication Patent
13988072 20130243857 10857102
Therapeutic Compositions Comprising Rilpivirine Hcl And Tenofovir Disopr... Therapeutic Compositions Comprising Rilpivirine Hcl And Tenofovir Disopr... Therapeutic Compositions Comprising Rilpivirine Hcl And Tenofovir Disopr...
10/29/2020
Gilead Sciences, Inc.
Assignor
Application Publication Patent
13988072 20130243857 10857102
Therapeutic Compositions Comprising Rilpivirine Hcl And Tenofovir Disopr... Therapeutic Compositions Comprising Rilpivirine Hcl And Tenofovir Disopr... Therapeutic Compositions Comprising Rilpivirine Hcl And Tenofovir Disopr...
9/28/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication
14771448 20160002155
9/28/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication
14771448 20160002155
9/28/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication Application
14771448 20160002155 10125094
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatmen... Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatmen...
9/28/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication Application
14771448 20160002155 10125094
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatmen... Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatmen...
9/20/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication
15534458 20170349602
9/20/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication
15534458 20170349602
9/20/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication Application
15534458 20170349602 10131673
Piperidine Substituted Tricyclic Pyrazolo[1,5-a]pyrimidine Derivatives W... Piperidine Substituted Tricyclic Pyrazolo[1,5-a]pyrimidine Derivatives W...
9/20/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication Application
15534458 20170349602 10131673
Piperidine Substituted Tricyclic Pyrazolo[1,5-a]pyrimidine Derivatives W... Piperidine Substituted Tricyclic Pyrazolo[1,5-a]pyrimidine Derivatives W...
8/7/2018
Janssen Pharmaceutica Nv
Assignor
Application Application Application Application Publication Publication Publication Publication Patent Application Application
15845854 14552108 15071612 15454703 20180105525 20150080413 20160194324 20170174683 9290493 9617262 9884864
Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht...
8/7/2018
Janssen Infectious Diseases - Diagnostic...
Assignor
Application Application Application Application Publication Publication Publication Publication Patent Application Application
15071612 15454703 15845854 14552108 20180105525 20150080413 20160194324 20170174683 9290493 9617262 9884864
Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht...
8/7/2018
Janssen-cilag
Assignor
Application Application Application Application Publication Publication Publication Publication Patent Application Application
14552108 15071612 15454703 15845854 20160194324 20170174683 20180105525 20150080413 9290493 9617262 9884864
Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht...
8/7/2018
Janssen Sciences Ireland Uc
Assignee
Application Application Application Publication Publication Publication Application Application
15845854 15071612 15454703 20160194324 20170174683 20180105525 9617262 9884864
8/7/2018
Janssen Pharmaceutica Nv
Assignor
Application Application Application Application Publication Publication Publication Publication Patent Application Patent Patent
15845854 14552108 15071612 15454703 20180105525 20150080413 20160194324 20170174683 9884864 10155759 9290493 9617262
Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht...
8/7/2018
Janssen Infectious Diseases - Diagnostic...
Assignor
Application Application Application Application Publication Publication Publication Publication Application Patent Patent Patent
15845854 14552108 15071612 15454703 20180105525 20150080413 20160194324 20170174683 10155759 9290493 9617262 9884864
Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht...
8/7/2018
Janssen-cilag
Assignor
Application Application Application Application Publication Publication Publication Publication Application Patent Patent Patent
15454703 15845854 14552108 15071612 20180105525 20150080413 20160194324 20170174683 10155759 9290493 9617262 9884864
Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht...
8/7/2018
Janssen Sciences Ireland Uc
Assignee
Application Application Application Publication Publication Publication Application Patent Patent
15845854 15071612 15454703 20180105525 20160194324 20170174683 10155759 9617262 9884864
Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht... Antibacterial Cyclopenta[c]pyrrole Substituted 3,4-dihydro-1h-[1,8]napht...
8/1/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication
14764138 20170260166
8/1/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication
14764138 20170260166
8/1/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication Application
14764138 20170260166 10081618
Quinoxalinones And Dihydroquinoxalinones As Respiratory Syncytial Virus ... Quinoxalinones And Dihydroquinoxalinones As Respiratory Syncytial Virus ...
8/1/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication Application
14764138 20170260166 10081618
Quinoxalinones And Dihydroquinoxalinones As Respiratory Syncytial Virus ... Quinoxalinones And Dihydroquinoxalinones As Respiratory Syncytial Virus ...
5/25/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication Application
15180603 20160296551 9987300
5/25/2018
Janssen Infectious Diseases Bvba
Assignor
Application Application Publication Publication Patent
15972840 15180603 20160296551 20180325939 9987300
Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm...
5/25/2018
Janssen Infectious Diseases Bvba
Assignor
Application Application Publication Publication Application Patent
15180603 15972840 20160296551 20180325939 10485816 9987300
Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm...
5/25/2018
Janssen Infectious Diseases Bvba
Assignor
Application Application Publication Publication Patent Patent
15180603 15972840 20160296551 20180325939 9987300 10485816
Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm...
5/25/2018
Janssen Sciences Ireland Uc
Assignee
Application Application Publication Publication Patent Patent
15180603 15972840 20160296551 20180325939 9987300 10485816
Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm... Polyinosinic-polycytidylic Acid (poly (i:c)) Formulations For The Treatm...
4/11/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication
15534442 20170349591
Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi... Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi...
4/11/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication
15534442 20170349591
Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi... Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi...
4/11/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication Application
15534442 20170349591 9981976
Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi... Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi...
4/11/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication Application
15534442 20170349591 9981976
Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi... Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi...
4/11/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication Patent
15534442 20170349591 9981976
Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi... Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi... Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi...
4/11/2018
Janssen Pharmaceutica Nv
Assignor
Application Publication Patent
15534442 20170349591 9981976
Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi... Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi... Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi...
4/11/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication Patent
15534442 20170349591 9981976
Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi... Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi... Piperidine Substituted Pyrazolo[1,5-a]pyrimidine Derivatives With Inhibi...
2/20/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication
15509474 20170253600
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen Pharmaceutica Nv
Assignor
Application Publication
15509474 20170253600
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen-cilag
Assignor
Application Publication
15509474 20170253600
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication
15509474 20170253600
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication Patent
15509474 20170253600 9932346
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen Pharmaceutica Nv
Assignor
Application Publication Patent
15509474 20170253600 9932346
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen-cilag
Assignor
Application Publication Patent
15509474 20170253600 9932346
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication Patent
15509474 20170253600 9932346
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen Infectious Diseases Bvba
Assignor
Application Publication Patent
15509474 20170253600 9932346
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen Pharmaceutica Nv
Assignor
Application Publication Patent
15509474 20170253600 9932346
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen-cilag
Assignor
Application Publication Patent
15509474 20170253600 9932346
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
2/20/2018
Janssen Sciences Ireland Uc
Assignee
Application Publication Patent
15509474 20170253600 9932346
Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection Pyrrolopyrimidines For Use In Influenza Virus Infection
8/21/2017
Janssen Sciences Ireland Uc
Assignee
Application Publication
14423981 20150274653
Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatmen... Sulfamoyl-arylamides And The Use Thereof As Medicaments For The Treatmen...
7/7/2017
Janssen Infectious Diseases Bvba
Assignor
Application Publication Patent
14781291 20160304531 10266543
Macrocyclic Deaza-purinones For The Treatment Of Viral Infections Macrocyclic Deaza-purinones For The Treatment Of Viral Infections Macrocyclic Deaza-purinones For The Treatment Of Viral Infections
7/7/2017
Janssen-cilag France
Assignor
Application Publication Patent
14781291 20160304531 10266543
Macrocyclic Deaza-purinones For The Treatment Of Viral Infections Macrocyclic Deaza-purinones For The Treatment Of Viral Infections Macrocyclic Deaza-purinones For The Treatment Of Viral Infections
7/7/2017
Janssen Sciences Ireland Uc
Assignee
Application Publication Patent
14781291 20160304531 10266543
Macrocyclic Deaza-purinones For The Treatment Of Viral Infections Macrocyclic Deaza-purinones For The Treatment Of Viral Infections Macrocyclic Deaza-purinones For The Treatment Of Viral Infections
Incoming Payments
Outgoing Payments